Center Director: Peter A. Jones, Ph.D., D.Sc. (hon)
Van Andel Institute’s Focal Centers in cancer and Parkinson’s are hubs for translating groundbreaking discoveries into clinical trials. Established in 2020, the VAI Cancer Center and VAI Parkinson’s Disease Center provide a support and infrastructure for scientists to develop and implement translational cancer and Parkinson’s disease projects in Grand Rapids and beyond, both in the lab and the clinic.
In the coming years, we expect the number of projects supported by Centers to grow, multiplying the Institute’s impact in cancer and Parkinson’s — diseases that affect millions of people around the world.
The Cancer Center supports projects and clinical trials in several different types of cancer in partnership with organizations in the U.S. and abroad.
Van Andel Institute–Stand Up To Cancer Epigenetics Dream Team
Finding the cancer therapies of tomorrow requires visionary thinking and innovative research today. The Van Andel Institute–Stand Up To Cancer (VAI–SU2C) Epigenetics Dream Team fosters collaboration between several of the world’s most respected research and clinical organizations in an effort to quickly move promising potential therapies into clinical trials. Learn more here.
We're raising thousands to save millions
We’re turning hope into action for the millions of people around the world affected by diseases like cancer and Parkinson’s. Find out how you can help us make a difference.
- 118 papers published in 2022
- 48 papers in high-impact journals in 2022
- 42 clinical trials launched